Status:
RECRUITING
Talk-to-Jo" Intelligent Digital Health Companion, Neurocognitive Disorders and Dyads
Lead Sponsor:
Olivier Beauchet
Collaborating Sponsors:
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Conditions:
Caregiver
Neurocognitive Disorders
Eligibility:
All Genders
65+ years
Brief Summary
By 2050, one in six people in the world will be over 65, leading to an increase in the number of people with neurocognitive disorders (NCD), such as Alzheimer's disease. The number of cases will rise ...
Eligibility Criteria
Inclusion
- Person living with an neurocognitive disorder (NCD):
- Inclusion criteria:
- Be 65 years old or older.
- Have an NCD, whether minor or major, in a mild to moderate stage, diagnosed within the past year.
- Be receiving care for an NCD at the outpatient clinic of the Montreal Geriatric University Institute.
- Have a caregiver.
- Live in a personal residence or in a non-medicalized senior residence.
- Be able to understand spoken and written French. The "Talk-to-Jo" avatar has only been developed in the French language and can only communicate and understand French.
- Exclusion criteria:
- Inability to provide informed consent for participation in the study.
- Participating in a concurrent experimental clinical study, to avoid interference with our study.
- Living in a Long-Term Care Facility or in a medicalized section of an non-medicalized senior residence.
- Inability to understand spoken and written French.
- Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
- Caregiver
- Inclusion criteria:
- Be a caregiver for a person living with an NCD (regardless of the relationship: spouse, child, friend, neighbor, family member).
- Be able to understand spoken and written French.
- Exclusion criteria:
- Have an NCD.
- Inability to understand spoken and written French.
- Participating in a concurrent experimental clinical study, to avoid interference with our study.
- Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
Exclusion
Key Trial Info
Start Date :
December 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06606353
Start Date
December 12 2024
End Date
October 1 2026
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRIUGM
Montreal, Quebec, Canada, H3W1W5